Glioblastoma Stem Cells Are Regulated by Interleukin-8 Signaling in a Tumoral Perivascular Niche

  • David W. Infanger
    Authors' Affiliations: Departments of 1Biomedical Engineering and 2Comparative Biomedical Sciences, 3Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, New York; 4Department of Veterinary Medicine, Colorado State University, Fort Collins, Colorado; and 5Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Department of Neurological Surgery, Weill Cornell Medical College, New York
  • YouJin Cho
    Authors' Affiliations: Departments of 1Biomedical Engineering and 2Comparative Biomedical Sciences, 3Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, New York; 4Department of Veterinary Medicine, Colorado State University, Fort Collins, Colorado; and 5Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Department of Neurological Surgery, Weill Cornell Medical College, New York
  • Brina S. Lopez
    Authors' Affiliations: Departments of 1Biomedical Engineering and 2Comparative Biomedical Sciences, 3Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, New York; 4Department of Veterinary Medicine, Colorado State University, Fort Collins, Colorado; and 5Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Department of Neurological Surgery, Weill Cornell Medical College, New York
  • Sunish Mohanan
    Authors' Affiliations: Departments of 1Biomedical Engineering and 2Comparative Biomedical Sciences, 3Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, New York; 4Department of Veterinary Medicine, Colorado State University, Fort Collins, Colorado; and 5Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Department of Neurological Surgery, Weill Cornell Medical College, New York
  • S. Chris Liu
    Authors' Affiliations: Departments of 1Biomedical Engineering and 2Comparative Biomedical Sciences, 3Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, New York; 4Department of Veterinary Medicine, Colorado State University, Fort Collins, Colorado; and 5Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Department of Neurological Surgery, Weill Cornell Medical College, New York
  • Demirkan Gursel
    Authors' Affiliations: Departments of 1Biomedical Engineering and 2Comparative Biomedical Sciences, 3Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, New York; 4Department of Veterinary Medicine, Colorado State University, Fort Collins, Colorado; and 5Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Department of Neurological Surgery, Weill Cornell Medical College, New York
  • John A. Boockvar
    Authors' Affiliations: Departments of 1Biomedical Engineering and 2Comparative Biomedical Sciences, 3Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, New York; 4Department of Veterinary Medicine, Colorado State University, Fort Collins, Colorado; and 5Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Department of Neurological Surgery, Weill Cornell Medical College, New York
  • Claudia Fischbach
    Authors' Affiliations: Departments of 1Biomedical Engineering and 2Comparative Biomedical Sciences, 3Kavli Institute at Cornell for Nanoscale Science, Cornell University, Ithaca, New York; 4Department of Veterinary Medicine, Colorado State University, Fort Collins, Colorado; and 5Laboratory for Translational Stem Cell Research, Weill Cornell Brain Tumor Center, Department of Neurological Surgery, Weill Cornell Medical College, New York

Abstract

<jats:title>Abstract</jats:title> <jats:p>Glioblastoma multiforme contains a subpopulation of cancer stem–like cells (CSC) believed to underlie tumorigenesis and therapeutic resistance. Recent studies have localized CSCs in this disease adjacent to endothelial cells (EC) in what has been termed a perivascular niche, spurring investigation into the role of EC–CSC interactions in glioblastoma multiforme pathobiology. However, these studies have been limited by a lack of in vitro models of three-dimensional disease that can recapitulate the relevant conditions of the niche. In this study, we engineered a scaffold-based culture system enabling brain endothelial cells to form vascular networks. Using this system, we showed that vascular assembly induces CSC maintenance and growth in vitro and accelerates tumor growth in vivo through paracrine interleukin (IL)-8 signaling. Relative to conventional monolayers, endothelial cells cultured in this three-dimensional system not only secreted enhanced levels of IL-8 but also induced CSCs to upregulate the IL-8 cognate receptors CXCR1 and CXCR2, which collectively enhanced CSC migration, growth, and stemness properties. CXCR2 silencing in CSCs abolished the tumor-promoting effects of endothelial cells in vivo, confirming a critical role for this signaling pathway in GMB pathogenesis. Together, our results reveal synergistic interactions between endothelial cells and CSCs that promote the malignant properties of CSCs in an IL-8–dependent manner. Furthermore, our findings underscore the relevance of tissue-engineered cell culture platforms to fully analyze signaling mechanisms in the tumor microenvironment. Cancer Res; 73(23); 7079–89. ©2013 AACR.</jats:p>

Journal

  • Cancer Research

    Cancer Research 73 (23), 7079-7089, 2013-12-01

    American Association for Cancer Research (AACR)

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top